Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure supports conjugation in drug design, especially in creating compounds targeting cancer and inflammatory diseases. The piperazine and carboxylic acid groups enable solubility and binding modifications, making it valuable in optimizing drug candidates for improved pharmacokinetics and target affinity.